{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:43:15Z","timestamp":1740166995597,"version":"3.37.3"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,20]]},"DOI":"10.1093\/ehjacc\/zuae149","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:09:34Z","timestamp":1735312174000},"page":"71-73","source":"Crossref","is-referenced-by-count":0,"title":["Ischaemic cardiogenic shock: should we consider basal inflammation\u2014and how? An editorial on the manuscript entitled: \u2018C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial\u2019"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-9687","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Roubille","sequence":"first","affiliation":[{"name":"PhyMedExp, Cardiology Department, University of Montpellier , INSERM U1046, CNRS UMR, 9214; INI-CRT, 34295 Montpellier ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"2025022010023167800_zuae149-B1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14779072.2017.1273771","article-title":"Anti-inflammatory drugs as promising cardiovascular treatments","volume":"15","author":"Huet","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2025022010023167800_zuae149-B2","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2025022010023167800_zuae149-B3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2025022010023167800_zuae149-B4","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"Back","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2025022010023167800_zuae149-B5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jchf.2023.05.007","article-title":"Clinical course of patients in cardiogenic shock stratified by phenotype","volume":"11","author":"Zweck","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2025022010023167800_zuae149-B6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock\u2014a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025022010023167800_zuae149-B7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.acvd.2019.02.001","article-title":"Design and preliminary results of FRENSHOCK 2016: a prospective nationwide multicentre registry on cardiogenic shock","volume":"112","author":"Delmas","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"issue":"5","key":"2025022010023167800_zuae149-B8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ehjacc\/zuad018","article-title":"Inflammatory response by 48\u2005h after admission and mortality in patients with acute myocardial infarction complicated by cardiogenic shock","volume":"12","author":"Kunkel","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2025022010023167800_zuae149-B9","doi-asserted-by":"crossref","first-page":"16338","DOI":"10.1038\/s41598-024-67556-y","article-title":"The admission level of CRP during cardiogenic shock is a strong independent risk marker of mortality","volume":"14","author":"Roubille","year":"2024","journal-title":"Sci Rep"},{"key":"2025022010023167800_zuae149-B10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejim.2009.11.011","article-title":"Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI","volume":"21","author":"Roubille","year":"2010","journal-title":"Eur J Intern Med"},{"key":"2025022010023167800_zuae149-B11","article-title":"Colchicine in acute myocardial infarction","author":"Jolly","year":"2024","journal-title":"N Engl J Med"},{"key":"2025022010023167800_zuae149-B12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000490881","article-title":"An hs-TNT second peak associated with high CRP at day 2 appears as potential biomarkers of micro-vascular occlusion on magnetic resonance imaging after reperfused ST-segment elevation myocardial infarction","volume":"140","author":"Huet","year":"2018","journal-title":"Cardiology"},{"key":"2025022010023167800_zuae149-B13","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"2025022010023167800_zuae149-B14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuae149\/61286673\/zuae149.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/14\/2\/71\/61286673\/zuae149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/14\/2\/71\/61286673\/zuae149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:02:50Z","timestamp":1740045770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/14\/2\/71\/7933738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,27]]},"published-print":{"date-parts":[[2025,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuae149","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"type":"print","value":"2048-8726"},{"type":"electronic","value":"2048-8734"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,27]]}}}